Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Clinical trial NCT03636256 · COMPLETED

Trial details

NCT number: NCT03636256
Sponsor: NanOlogy, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Urothelial Carcinoma Urinary Bladder Neoplasm Urinary Bladder Cancer Urogenital Neoplasms Urologic Neoplasms Urologic Cancer Malignant Tumor of the Urinary Bladder Cancer of the Bladder

Start date: 2019-04-02
Primary completion: 2021-11-02
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.